Oligoprogression in Non-Small Cell Lung Cancer

We reviewed the literature on oligoprogressive disease (OPD) and local ablative therapy (LAT) in patients with advanced non-small cell lung cancer (NSCLC). The frequency of OPD varies depending on its definition and is estimated to be between 15–47%. The implications of the strategy of continuing th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daijiro Harada, Nagio Takigawa
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/8a9c547006e546d2b1c06ebecb252fe7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!